India to United States: Diltiazem Export Trade Route
India has recorded 155 verified shipments of Diltiazem exported to United States, representing a combined trade value of $8.6M USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $55.3K USD. The leading Indian exporter is MAIVA PHARMA PRIVATE LIMITED, which accounts for 27% of total export value with 47 shipments worth $2.3M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $2.3M USD in purchases. The top 3 suppliers — MAIVA PHARMA PRIVATE LIMITED, PIRAMAL PHARMA LIMITED, GLOBAL PHARMATECH PRIVATE LIMITED — together control 56% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Diltiazem corridor is one of India's established pharmaceutical export routes, with 155 shipments documented worth a combined $8.6M USD. The route is dominated by MAIVA PHARMA PRIVATE LIMITED, which alone accounts for roughly 27% of all export value, reflecting the consolidated nature of India's diltiazem manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $55.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #5 among India's top diltiazem export destinations globally.
On the import side, key buyers of Indian diltiazem in United States include EVERSANA LIFE SCIENCE SERVICES, TEVA PHARMACEUTICALS USA, INC, EVERSANA LIFESCIENCE SERVICES and 22 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 47 shipments valued at $2.3M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portPLOT 53, SIPCOT IND.
Market Position
- Global rank#5
- Annual growth+28.2%
- Demand growth+23.7%
- Regulatory ease68/100
Top 10 Indian Diltiazem Exporters to United States
Showing top 10 of 15 Indian suppliers exporting Diltiazem to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MAIVA PHARMA PRIVATE LIMITED Avg $49.3K per shipment | 47 | $2.3M | 27.1% |
| 2 | PIRAMAL PHARMA LIMITED Avg $52.3K per shipment | 27 | $1.4M | 16.5% |
| 3 | GLOBAL PHARMATECH PRIVATE LIMITED Avg $84.9K per shipment | 13 | $1.1M | 12.9% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED Avg $94.1K per shipment | 11 | $1.0M | 12.1% |
| 5 | MYLAN LABORATORIES LIMITED Avg $39.4K per shipment | 22 | $866.5K | 10.1% |
| 6 | INTAS PHARMACEUTICALS LIMITED Avg $59.0K per shipment | 10 | $590.2K | 6.9% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED Avg $103.5K per shipment | 5 | $517.7K | 6.0% |
| 8 | CADILA HEALTHCARE LTD Avg $92.5K per shipment | 4 | $370.1K | 4.3% |
| 9 | ALEMBIC PHARMACEUTICALS LTD Avg $29.1K per shipment | 4 | $116.5K | 1.4% |
| 10 | GLENMARK PHARMACEUTICALS LIMITED Avg $49.1K per shipment | 2 | $98.3K | 1.1% |
This table shows the top 10 of 15 Indian companies exporting diltiazem to United States, ranked by total trade value. The listed exporters are: MAIVA PHARMA PRIVATE LIMITED, PIRAMAL PHARMA LIMITED, GLOBAL PHARMATECH PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, CADILA HEALTHCARE LTD, ALEMBIC PHARMACEUTICALS LTD, GLENMARK PHARMACEUTICALS LIMITED. MAIVA PHARMA PRIVATE LIMITED is the dominant supplier with 47 shipments worth $2.3M USD, giving it a 27% market share. The top 3 suppliers together account for 56% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to United States Diltiazem export route.
Top 10 Diltiazem Importers in United States
Showing top 10 of 25 known buyers in United States receiving Diltiazem shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian diltiazem in United States include EVERSANA LIFE SCIENCE SERVICES, TEVA PHARMACEUTICALS USA, INC, EVERSANA LIFESCIENCE SERVICES, EUGIA US LLC, J. KNIPPER & COMPANY, among 25 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $2.3M USD across 47 shipments — representing 27% of all diltiazem imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 47 | $2.3M | 26.6% |
| 2 | TEVA PHARMACEUTICALS USA, INC | 18 | $989.7K | 11.6% |
| 3 | EVERSANA LIFESCIENCE SERVICES | 8 | $673.3K | 7.9% |
| 4 | EUGIA US LLC | 9 | $615.2K | 7.2% |
| 5 | J. KNIPPER & COMPANY | 5 | $517.7K | 6.0% |
| 6 | MYLAN PHARMACEUTICALS INC | 15 | $508.9K | 5.9% |
| 7 | TEVA PHARMACEUTICALS USA INC | 9 | $422.6K | 4.9% |
| 8 | EUGIA US LLC, | 2 | $420.0K | 4.9% |
| 9 | ZYDUS PHARMACEUTICALS USA INC | 5 | $410.8K | 4.8% |
| 10 | EVERSANA LIFE SCIENCES SERVICES LLC | 4 | $344.0K | 4.0% |
Showing top 10 of 25 Diltiazem importers in United States on this route.
Top 10 Diltiazem Formulations Imported by United States
Showing top 10 of 111 product formulations shipped on the India to United States Diltiazem route, ranked by trade value
United States imports a wide range of diltiazem formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TIADYLT ER DILTIAZEM HCL ER CAPS USP — accounts for $370.1K USD across 4 shipments. There are 111 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TIADYLT ER DILTIAZEM HCL ER CAPS USP | 4 | $370.1K | 4.3% |
| 2 | DILTIAZEM HYDROCHLORIDE INJECTION 125MG/ | 1 | $301.9K | 3.5% |
| 3 | "(400825006) DILTIAZEM HCL TABLETS 120MG100 (QUANTITY : 37,104.000 ECH ) | 2 | $240.1K | 2.8% |
| 4 | DILTIAZEM HCL ER CAP, USP120MG100TC_APUS | 2 | $239.7K | 2.8% |
| 5 | DILTIAZEM HCL INJECTION 25MG PER 5ML 5MG/ML BATCH NO:E002A021. MANUFACTURING DT:09/2023 EXP DT:08/2025 | 2 | $188.4K | 2.2% |
| 6 | DILTIAZEM HCL INJECTION 25MG PER 5ML 5MG/ML BATCH NO:E002A019. MANUFACTURING DT:09/2023 EXP DT:08/2025 | 2 | $188.0K | 2.2% |
| 7 | DILTIAZEM HCL INJECTION 25MG PER 5ML 5MG/ML BATCH NO:E002A020. MANUFACTURING DT:09/2023 EXP DT:08/2025 | 2 | $187.7K | 2.2% |
| 8 | PHARMA DRUGS & MEDI DILTIAZEM HCL ER USP | 4 | $186.7K | 2.2% |
| 9 | PHR DRUGS MEDI DILTIAZEM HCL ER USP 240100C ACC US EACH EXTENDED RELEASE CAPSULE CONTAINS DILTIAZEM HYDROCHLORIDE USP | 2 | $166.3K | 1.9% |
| 10 | Diltiazem Hcl Injection 125mg per 25ml | 2 | $152.4K | 1.8% |
Showing top 10 of 111 Diltiazem formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
PLOT 53, SIPCOT IND. handles the highest volume with 30 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's diltiazem exports to United States are driven primarily by a handful of large-scale manufacturers. MAIVA PHARMA PRIVATE LIMITED with 47 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MAIVA PHARMA PRIVATE LIMITED, PIRAMAL PHARMA LIMITED, GLOBAL PHARMATECH PRIVATE LIMITED — together account for 56% of total trade value on this route. The average shipment value of $55.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as diltiazem hydrochloride injection 125mg/ and "(400825006) diltiazem hcl tablets 120mg100 (quantity : 37,104.000 ech ), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 47 shipments worth $2.3M USD — representing 27% of all diltiazem imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $8.6M
- Avg. Shipment
- $55.3K
- Suppliers
- 15
- Buyers
- 25
- Transit (Sea)
- ~15 days
- Annual Growth
- +28.2%
Reverse Direction
United States → India — Diltiazem (Import)Other Diltiazem Routes
Unlock the Full India to United States Diltiazem Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 155 shipments on this route.
Frequently Asked Questions — India to United States Diltiazem Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Diltiazem to United States?
The leading Indian exporters of Diltiazem to United States are MAIVA PHARMA PRIVATE LIMITED, PIRAMAL PHARMA LIMITED, GLOBAL PHARMATECH PRIVATE LIMITED. MAIVA PHARMA PRIVATE LIMITED holds the largest market share at approximately 27% of total trade value on this route.
Q What is the total value of Diltiazem exports from India to United States?
India exports Diltiazem to United States worth approximately $8.6M USD across 155 recorded shipments. The average value per shipment is $55.3K USD.
Q Which ports does India use to ship Diltiazem to United States?
The most active port of origin is PLOT 53, SIPCOT IND. with 30 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Diltiazem?
The average transit time for Diltiazem shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Diltiazem trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.2% with demand growth tracking at 23.7%. The route is ranked #5 among India's top Diltiazem export destinations globally.
Q How many suppliers are active on the India to United States Diltiazem route?
There are currently 15 active Indian suppliers exporting Diltiazem to United States. The market is moderately concentrated with MAIVA PHARMA PRIVATE LIMITED accounting for 27% of total shipment value.
Q Who are the main importers of Diltiazem from India in United States?
The leading importers of Indian Diltiazem in United States include EVERSANA LIFE SCIENCE SERVICES, TEVA PHARMACEUTICALS USA, INC, EVERSANA LIFESCIENCE SERVICES, EUGIA US LLC, J. KNIPPER & COMPANY. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 47 shipments worth $2.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Diltiazem.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 25 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 155 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
155 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists